This statistic shows the global spending on diabetes in developed and so called pharmerging markets from 2013 to 2018. In 2013, the developed diabetes market expended 35 billion U.S. dollars. Among others, growth in spending is driven by the increasing price of modern insulin in the United States. In developed markets, new therapies targeting diabetes is a significant driver of market growth.
Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
* Developed: U.S., Japan, Germany, France, Italy, Spain, U.K., Canada, South Korea. Pharmerging: China, Brazil, Russia, India, Algeria, Argentina, Colombia, Egypt,
Indonesia, Mexico, Nigeria, Pakistan, Poland, Romania, Saudi Arabia, South Africa, Thailand, Turkey, Ukraine, Venezuela, Vietnam. Class forecasts adapted from
IMS Market Prognosis September 2014. Spending in US$ with variable exchange rates. Growth in US$ at constant exchange rates.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health (Institute for Healthcare Informatics). (November 24, 2014). Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). "Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*." Chart. November 24, 2014. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). (2014). Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). "Diabetes Spending in Developed and Pharmerging Markets from 2013 to 2018 (in Billion U.S. Dollars)*." Statista, Statista Inc., 24 Nov 2014, https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics), Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/ (last visited November 10, 2024)
Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* [Graph], IMS Health (Institute for Healthcare Informatics), November 24, 2014. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/373981/global-spending-on-diabetes-by-market/
